Niemann-Pick disease type C: analysis of 7 patients

详细信息    查看全文

• 作者：Hui Xiong (1)
  Xin-Hua Bao (1)
  Yue-Hua Zhang (1)
  You-Ning Xu (2)
  Jiong Qin (1)
  Hui-Ping Shi (3)
  Xi-Ru Wu (1)
  
• 关键词：Niemann ; Pick disease type C ; sea ; blue cells ; vertical supranuclear gaze palsy
• 刊名：World Journal of Pediatrics
• 出版年：2012
• 出版时间：February 2012
• 年：2012
• 卷：8
• 期：1
• 页码：61-66
• 全文大小：400KB
• 参考文献：1. Kolodny EH. Niemann-Pick disease. Curr Opin Hematol 2000;7:48鈥?2. CrossRef
  2. Tang Y, Li H, Liu JP. Niemann-Pick disease type C: from molecule to clinic. Clin Exp Pharmacol Physiol 2010;37:132鈥?40. CrossRef
  3. Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis 2010;5:16. CrossRef
  4. Garver WS, Francis GA, Jelinek D, Shepherd G, Flynn J, Castro G, et al. The National Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A 2007;143A:1204鈥?211. CrossRef
  5. Grau AJ, Weisbrod M, Hund E, Harzer K. Niemann-Pick disease type C鈥攁 neurometabolic disease through disturbed intracellular lipid transport. Nervenarzt 2003;74:900鈥?05. CrossRef
  6. Ramirez CM, Liu B, Taylor AM, Repa JJ, Burns DK, Weinberg AG, et al. Weekly cyclodextrin administration normalizes cholesterol metabolism in nearly every organ of the Niemann-Pick type C1 mouse and markedly prolongs life. Pediatr Res 2010;68:309鈥?15. CrossRef
  7. Rosenbaum AI, Cosner CC, Mariani CJ, Maxfield FR, Wiest O, Helquist P. Thiadiazole Carbamates: potent inhibitors of lysosomal acid lipase and potential Niemann-Pick type C disease therapeutics. J Med Chem 2010;53:5281鈥?289. CrossRef
  8. Wraith JE, Vecchio D, Jacklin E, Abel L, Chadha-Boreham H, Luzy C, et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab 2010;99:351鈥?57. CrossRef
  9. Lyu RK, Ko YM, Hung IJ, Lu CS. Type C Niemann-Pick disease: report of a Chinese case. J Formos Med Assoc 1993;92:829鈥?31.
  10. Yang CC, Su YN, Chiou PC, Fietz MJ, Yu CL, Hwu WL, et al. Six novel NPC1 mutations in Chinese patients with Niemann-Pick disease type C. J Neurol Neurosurg Psychiatry 2005;76:592鈥?95. CrossRef
  11. Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, Mengel E, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab 2009;98:152鈥?65. CrossRef
  12. Elleder M, Jirasek A, Smid F, Ledvinova J, Besley GT. Niemann-Pick disease type C. Study on the nature of the cerebral storage process. Acta Neuropathol 1985;66:325鈥?36.
  13. Vanier MT, Millat G. Niemann-Pick disease type C. Clin Genet 2003;64:269鈥?81. CrossRef
  14. Tamura H, Takahashi T, Ban N, Torisu H, Ninomiya H, Takada G, et al. Niemann-Pick type C disease: novel NPC1 mutations and characterization of the concomitant acid sphingomyelinase deficiency. Mol Genet Metab 2006;87:113鈥?21. CrossRef
  15. Lloyd-Evans E, Morgan AJ, He X, Smith DA, Elliot-Smith E, Sillence DJ, et al. Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 2008;14:1247鈥?255. CrossRef
  16. Garver WS, Jelinek D, Meaney FJ, Flynn J, Pettit KM, Shepherd G, et al. The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes. J Lipid Res 2010;51:406鈥?15. CrossRef
  17. Infante RE, Wang ML, Radhakrishnan A, Kwon HJ, Brown MS, Goldstein JL. NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes. Proc Natl Acad Sci U S A 2008;105:15287鈥?5292. CrossRef
  18. Candoni A, Grimaz S, Doretto P, Fanin R, Falcomer F, Bembi B. Sea-blue histiocytosis secondary to Niemann-Pick disease type B: a case report. Ann Hematol 2001;80:620鈥?22. CrossRef
  19. Lossos A, Schlesinger I, Okon E, Abramsky O, Bargal R, Vanier MT, et al. Adult-onset Niemann-Pick type C disease. Clinical, biochemical, and genetic study. Arch Neurol 1997;54:1536鈥?541.
  20. Sevin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, et al. The adult form of Niemann-Pick disease type C. Brain 2007;130:120鈥?33. CrossRef
  21. Watanabe Y, Akaboshi S, Ishida G, Takeshima T, Yano T, Taniguchi M, et al. Increased levels of GM2 ganglioside in fibroblasts from a patient with juvenile Niemann-Pick disease type C. Brain Dev 1998;20:95鈥?7. CrossRef
  22. Canafoglia L, Bugiani M, Uziel G, Dalla Bernardina B, Ciano C, Scaioli V, et al. Rhythmic cortical myoclonus in Niemann-Pick disease type C. Mov Disord 2006;21:1453鈥?456. CrossRef
  23. Battisti C, Tarugi P, Dotti MT, De Stefano N, Vattimo A, Chierichetti F, et al. Adult onset Niemann-Pick type C disease: a clinical, neuroimaging and molecular genetic study. Mov Disord 2003;18:1405鈥?409. CrossRef
  24. Lengyel D, Weissert M, Schmid L, Gottlob I. Eye movement abnormalities as a sign for the diagnosis in Niemann-Pick disease type C. Klin Monbl Augenheilkd 1999;214:50鈥?2. CrossRef
  25. Omarini LP, Frank-Burkhardt SE, Seemayer TA, Mentha G, Terrier F. Niemann-Pick disease type C: nodular splenomegaly. Abdom Imaging 1995;20:157鈥?60. CrossRef
  26. Patterson M. Niemann-Pick Disease Type C. In: Pagon RA, Bird TC, Dolan CR, Stephens K, eds. Gene Reviews. Seattle: University of Washington, 2008.
  27. Pineda M, Perez-Poyato MS, O鈥機allaghan M, Vilaseca MA, Pocovi M, Domingo R, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Mol Genet Metab 2010;99:358鈥?66. CrossRef
  28. Bae JS, Carter JE, Jin HK. Adipose tissue-derived stem cells rescue Purkinje neurons and alleviate infl ammatory responses in Niemann-Pick disease type C mice. Cell Tissue Res 2010;340:357鈥?69. CrossRef
  29. Hsu YS, Hwu WL, Huang SF, Lu MY, Chen RL, Lin DT, et al. Niemann-Pick disease type C (a cellular cholesterol lipidosis) treated by bone marrow transplantation. Bone Marrow Transplant 1999;24:103鈥?07. CrossRef
  30. Yanjanin NM, Velez JI, Gropman A, King K, Bianconi SE, Conley SK, et al. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet 2010;153B:132鈥?40.
  
• 作者单位：Hui Xiong (1)
  Xin-Hua Bao (1)
  Yue-Hua Zhang (1)
  You-Ning Xu (2)
  Jiong Qin (1)
  Hui-Ping Shi (3)
  Xi-Ru Wu (1)
  
  1. Department of Pediatrics, Peking University First Hospital, Beijing, 100034, China
  2. Department of Pediatrics, Beijing Changping District Hospital, Beijing, China
  3. Department of Genetics, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
  

文摘

Background Niemann-Pick disease type C (NP-C), derived from mutation of the NPC1 or NPC2 gene, is one of the recessive lysosomal lipid storage disorders that are difficult to diagnose and treat. Since NP-C has been rarely reported in China, we reviewed 7 patients with NP-C. Methods The 7 patients had been diagnosed with NP-C from 2007 to 2010 at our department and their laboratory and clinical data were analyzed. Results The 7 patients, 5 males and 2 females, included 4 patients of late infantile subtype and 3 patients of juvenile subtype, in which patients 2 and 3 were siblings. Their clinical symptoms occurred from 4 to 10 years of age, exhibiting as progressive cognitive and language impairment as well as motor retrogression. Six patients were caught by focal or generalized seizures from 1 to 4 years after the onset of the disease. Vertical supranuclear gaze palsy, dysarthria, dysphagia, internal rotation and adduction of bilateral hands and splenomegaly occurred following the progress of clinical symptoms. Five patients had laughter-cataplexy. MRI showed mild brain atrophy in 6 patients. Reduction of total cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol occurred in 6 patients. Sea-blue cells and Niemann-Pick cells were found in bone marrow smears. The activity of acid sphingomyelin enzyme was normal or only slightly lower. Supporting or symptomatic treatment improved common clinical symptoms. Conclusions NP-C is a rare autosomal recessive inherited lysosomal storage disease that affects the intellectual development of children and may lead to dementia, vegetative state or death. Clinical features of this disease include vertical supranuclear gaze palsy, seizures and cataplexy. Laboratory features include abnormal plasma cholesterol level, and sea-blue cells and Niemann-Pick cells in bone marrow smears. The treatments of the disease include supporting or symptomatic administration.